Diazepam binding inhibitor-like 5 pseudogene 2 (DBIL5P2)

DBIL5P2 (Diazepam binding inhibitor-like 5 pseudogene 2) is a processed pseudogene located on the reverse strand of chromosome 2, with various database accessions such as ENSG00000242412 and ENSG00000293077[1][3][7]. It is also called ELP1P (endozepine-like peptide 1 pseudogene). Unlike canonical protein-coding genes, pseudogenes like DBIL5P2 generally do not encode functional proteins because they contain disabling mutations such as premature stop codons, frameshifts, or lack regulatory elements needed for transcription/translation[4]. While most pseudogenes have historically been seen as non-functional, recent research highlights possible regulatory functions through RNA-mediated mechanisms and epigenetic modulation; however, these roles are gene-specific and no evidence currently supports DBIL5P2 itself being a functional gene or valid therapeutic target[4][7]. Pseudogenes, including DBIL5P2, are not considered receptors, enzymes, transporters, or direct pharmacological targets in the context of drug discovery. There is no record of DBIL5P2 encoding a protein, nor of any known drugs interacting with this locus, nor biomarker, safety concern, or concrete disease association specific to this pseudogene. Pseudogenes as a class may participate in gene expression regulation, and some are increasingly studied for associations with cancer or other diseases, but no evidence as of now substantiates DBIL5P2 as a specific disease marker or target[4][6][7]. If you require structured information as described, the majority of entries should be set to null or "Other" for DBIL5P2, as it is not an established functional drug target. If you need details on the related functional gene (for example, "Diazepam binding inhibitor" or "Acyl-CoA-binding protein"), further search would be necessary.

Other names

ELP1Pendozepine-like peptide 1 pseudogeneENSG00000242412ENSG00000293077